X-Chem

Glamorous AI develops an artificial intelligence-based drug discovery platform that focuses on low-data scenarios in pharmaceutical research. The platform utilizes AI to identify and optimize novel chemical compounds, facilitating the discovery of new medicines by analyzing prior experimental results. It is designed to handle sparse, noisy, and small datasets, making it particularly effective for tackling complex drug discovery challenges. By leveraging a large repository of pre-trained and customizable AI models, Glamorous AI enables researchers to screen extensive chemical libraries and address novel and first-in-class therapeutic targets, ultimately driving innovation in drug development and contributing to the advancement of treatments for various diseases.

ComInnex specializes in synthetic chemistry services and innovative chemical technologies, primarily supporting early-stage drug discovery. The company operates as a chemistry research organization that emphasizes open communication and adaptability to meet client needs. ComInnex provides a range of services, including small molecule design, chemical library development and synthesis, project management, and customer support. Its clientele includes pharmaceutical companies, biotechnology start-ups, academic institutions, non-profit organizations, and government agencies worldwide. The company is committed to ensuring both timeliness and confidentiality in its operations.

IntelliSyn providers of medicinal chemistry support in North America. Our team of experienced scientists (>80% PhD), at our state-of-the-art facilities in Montreal, specializes in identifying novel leads and optimizing them as successful clinical candidates for our collaborators across Major Pharma and Biotech. IntelliSyn provide discovery support (computational chemistry, design, synthesis, and DMPK) where innovation, intellectual property security, and proven delivery-expertise are needed on an expert basis. Our discipline expertise ranges across CNS, oncology, metabolic diseases as well as other specialized areas including structure-based design, GPCR modulators, and ion channel modulators.